Xavier Guille des Buttes
Direktor/Vorstandsmitglied bei GENFIT
Vermögen: 6 303 $ am 30.04.2024
Aktive Positionen von Xavier Guille des Buttes
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
GENFIT | Direktor/Vorstandsmitglied | 16.06.2017 | - |
Independent Dir/Board Member | 18.10.2006 | - | |
Vorsitzender | 18.10.2006 | 16.06.2017 | |
Somedial SpA | Direktor/Vorstandsmitglied | 19.07.2010 | - |
Hemarina SA
Hemarina SA BiotechnologyHealth Technology Hemarina SA operates as a biotechnology company which develops oxygen carrier for therapeutic and industrial applications. It offers organ preservation, wound healing, hemoglobin oxygen-carrier, cell culture and bioproduction and other perspective products. The company was founded by Franck Zal, Elisabeth Leize, Morgane Rousselot and Laurent Meijer on March 26, 2007 and is headquartered in Morlaix, France. | Direktor/Vorstandsmitglied | - | - |
Delpharm SAS
Delpharm SAS Pharmaceuticals: MajorHealth Technology Delpharm SAS develops and manufactures drugs. The company is headquartered in Issy-les-Moulineaux, France. | Corporate Officer/Principal | - | - |
Université Catholique de Lille | Vorsitzender | - | - |
IBA Molecular Holding SA
IBA Molecular Holding SA Pharmaceuticals: MajorHealth Technology IBA Molecular Holding SA develops and markets leading edge technologies, pharmaceuticals and tailor made solutions for healthcare with a focus on cancer diagnosis and therapy. The firm serves the medical and healthcare industries. The company is headquartered in Louvain-la-Neuve, Belgium. | Direktor/Vorstandsmitglied | 17.03.2006 | - |
Karriereverlauf von Xavier Guille des Buttes
Ehemalige bekannte Positionen von Xavier Guille des Buttes
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Bayer Schering Pharma AG | Vorstandsvorsitzender | - | 01.06.2006 |
Delpharm Holding SASU
Delpharm Holding SASU Pharmaceuticals: MajorHealth Technology Delpharm Holding SASU was engaged in pharmaceutical development and contract manufacturing services. Its activities included secondary manufacturing and processing, packaging and labeling of finished products, and branded prescription products. The company was founded on March 29, 2011 and was headquartered in Boulogne-Billancourt, France. | Direktor/Vorstandsmitglied | - | - |
Ouest Angels Developpment SAS
Ouest Angels Developpment SAS Financial ConglomeratesFinance Ouest Angels Developpment operates as a business organization, with interest in the promotion of equity, start-up, and other private investment activities. The company was founded by Henry De Champsavin in 2007 and is headquartered in Nantes, France. | Direktor/Vorstandsmitglied | - | - |
░░░░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Xavier Guille des Buttes
L'Ecole Superieure des Sciences Commerciales d'Angers | Undergraduate Degree |
Institut Supérieur de Commerce International de Dunkerque | Undergraduate Degree |
Institut de Contrôle de Gestion | Undergraduate Degree |
Statistik
International
Frankreich | 11 |
Algerien | 2 |
China | 2 |
Operativ
Director/Board Member | 8 |
Undergraduate Degree | 3 |
Chairman | 2 |
Sektoral
Health Technology | 9 |
Consumer Services | 5 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
GENFIT | Health Technology |
Private Unternehmen | 9 |
---|---|
DIAGAST SAS
DIAGAST SAS Pharmaceuticals: MajorHealth Technology DIAGAST SAS operates as a blood matching company. Its products include QWALYS range, Erythrocytes Magnetized technology, manual range, PK 7300 ranges, pre-transfusion control, disposable plates and technical inserts. The company was founded in 1968 and is headquartered in Loos, France. | Health Technology |
Somedial SpA | |
Financière Delpharm SAS
Financière Delpharm SAS Pharmaceuticals: MajorHealth Technology Financière Delpharm SAS operates as a holding company with interests in the manufacturing of pharmaceuticals. The company was founded on 25 March 2004 and is headquartered in Issy-les-Moulineaux, France. | Health Technology |
Hemarina SA
Hemarina SA BiotechnologyHealth Technology Hemarina SA operates as a biotechnology company which develops oxygen carrier for therapeutic and industrial applications. It offers organ preservation, wound healing, hemoglobin oxygen-carrier, cell culture and bioproduction and other perspective products. The company was founded by Franck Zal, Elisabeth Leize, Morgane Rousselot and Laurent Meijer on March 26, 2007 and is headquartered in Morlaix, France. | Health Technology |
Bayer Schering Pharma AG | Health Technology |
Ouest Angels Developpment SAS
Ouest Angels Developpment SAS Financial ConglomeratesFinance Ouest Angels Developpment operates as a business organization, with interest in the promotion of equity, start-up, and other private investment activities. The company was founded by Henry De Champsavin in 2007 and is headquartered in Nantes, France. | Finance |
Delpharm SAS
Delpharm SAS Pharmaceuticals: MajorHealth Technology Delpharm SAS develops and manufactures drugs. The company is headquartered in Issy-les-Moulineaux, France. | Health Technology |
Delpharm Holding SASU
Delpharm Holding SASU Pharmaceuticals: MajorHealth Technology Delpharm Holding SASU was engaged in pharmaceutical development and contract manufacturing services. Its activities included secondary manufacturing and processing, packaging and labeling of finished products, and branded prescription products. The company was founded on March 29, 2011 and was headquartered in Boulogne-Billancourt, France. | Health Technology |
IBA Molecular Holding SA
IBA Molecular Holding SA Pharmaceuticals: MajorHealth Technology IBA Molecular Holding SA develops and markets leading edge technologies, pharmaceuticals and tailor made solutions for healthcare with a focus on cancer diagnosis and therapy. The firm serves the medical and healthcare industries. The company is headquartered in Louvain-la-Neuve, Belgium. | Health Technology |